Metric Finance
LearnFAQ
LearnFAQ

Learn / LBRX

NASDAQ: LBRX

Lb Pharmaceuticals (LBRX) stock, explained like you're 5

Lb Pharmaceuticals trades on the Nasdaq under the ticker LBRX. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.2 billion dollars.

Ticker
LBRX
Exchange
Nasdaq
Sector
Healthcare
Industry
Pharmaceutical Preparations
Size
Small cap, about 1.2 billion dollars

Is Lb Pharmaceuticals a small, medium or large cap company?

No. Lb Pharmaceuticals is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.2 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Lb Pharmaceuticals makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves LBRX stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • LB Pharmaceuticals (NASDAQ:LBRX) Stock Jumps 8.8% Should You Buy? (MarketBeat)
  • A 200,000 share option award for LB Pharmaceuticals (LBRX) CFO carries a $37.22 exercise price. (Stock Titan)
  • LB Pharmaceuticals (LBRX) Stock Fair Value Rises As LB 102 Outlook Shifts (Yahoo Finance)
  • Guggenheim reiterates LB Pharmaceuticals stock rating on study data (Investing.com)
  • LB Pharmaceuticals (NasdaqGM:LBRX) Stock Price (Simply Wall Street)

Follow LBRX in your daily brief

Each trading day at 5 PM ET we post what happened to Lb Pharmaceuticals and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow LBRX

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Lb Pharmaceuticals stock

What does Lb Pharmaceuticals do?

Lb Pharmaceuticals trades on the Nasdaq under the ticker LBRX. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.2 billion dollars.

What is the ticker symbol for Lb Pharmaceuticals?

Lb Pharmaceuticals trades under the ticker LBRX on the Nasdaq.

What is Lb Pharmaceuticals's market cap?

Lb Pharmaceuticals is a small cap stock with a market cap of about 1.2 billion dollars.

How does Lb Pharmaceuticals make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves LBRX stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow LBRX stock every day?

Add LBRX to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow LBRX daily

A free brief on Lb Pharmaceuticals and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • NVS · Novartis AG
  • AZN · Astrazeneca PLC
  • NVO · Novo Nordisk A S
  • VRTX · Vertex Pharmaceuticals Inc / Ma

Similar stocks

  • NVSNovartis AG
  • AZNAstrazeneca PLC
  • NVONovo Nordisk A S
  • VRTXVertex Pharmaceuticals Inc / Ma

Compare LBRX: LBRX vs NVS, LBRX vs AZN, LBRX vs NVO

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed